Manufacturers Life Insurance Company, The Tg Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $109 Billion
  • Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 75,327 shares of TGTX stock, worth $3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,327
Previous 79,191 4.88%
Holding current value
$3 Million
Previous $1.85 Million 22.41%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$21.31 - $35.09 $82,341 - $135,587
-3,864 Reduced 4.88%
75,327 $2.27 Million
Q3 2024

Nov 13, 2024
SELL
$17.21 - $25.28 $25,350 - $37,237
-1,473 Reduced 1.83%
79,191 $1.85 Million
Q2 2024

Aug 14, 2024
BUY
$13.32 - $19.19 $38,241 - $55,094
2,871 Added 3.69%
80,664 $1.44 Million
Q1 2024

May 14, 2024
BUY
$13.02 - $21.3 $98,665 - $161,411
7,578 Added 10.79%
77,793 $1.18 Million
Q4 2023

Feb 13, 2024
SELL
$6.68 - $18.81 $8,176 - $23,023
-1,224 Reduced 1.71%
70,215 $1.2 Million
Q3 2023

Nov 15, 2023
BUY
$8.36 - $26.5 $13,660 - $43,301
1,634 Added 2.34%
71,439 $597,000
Q2 2023

Aug 11, 2023
BUY
$15.48 - $35.0 $274,986 - $621,740
17,764 Added 34.13%
69,805 $1.73 Million
Q1 2023

May 15, 2023
BUY
$10.23 - $19.34 $22,485 - $42,509
2,198 Added 4.22%
54,239 $815,000
Q4 2022

Aug 11, 2023
BUY
$5.01 - $11.83 $8,992 - $21,234
1,795 Added 3.57%
52,041 $615,000
Q4 2022

Feb 13, 2023
BUY
$5.01 - $11.83 $8,992 - $21,234
1,795 Added 3.57%
52,041 $615,000
Q3 2022

Aug 11, 2023
SELL
$4.57 - $8.4 $10,177 - $18,706
-2,227 Reduced 4.24%
50,246 $297,000
Q3 2022

Nov 03, 2022
SELL
$4.57 - $8.4 $10,177 - $18,706
-2,227 Reduced 4.24%
50,246 $297,000
Q2 2022

Aug 11, 2023
BUY
$3.74 - $10.66 $4,738 - $13,506
1,267 Added 2.47%
52,473 $223,000
Q2 2022

Aug 15, 2022
BUY
$3.74 - $10.66 $4,738 - $13,506
1,267 Added 2.47%
52,473 $223,000
Q1 2022

Aug 11, 2023
SELL
$7.81 - $20.45 $23,687 - $62,024
-3,033 Reduced 5.59%
51,206 $486,000
Q1 2022

May 20, 2022
SELL
$7.81 - $20.45 $95,360 - $249,694
-12,210 Reduced 19.25%
51,206 $487,000
Q4 2021

Feb 16, 2022
BUY
$15.2 - $35.51 $1,444 - $3,373
95 Added 0.15%
63,416 $1.21 Million
Q3 2021

Nov 12, 2021
SELL
$21.78 - $40.45 $132,182 - $245,491
-6,069 Reduced 8.75%
63,321 $2.11 Million
Q2 2021

Aug 12, 2021
BUY
$32.5 - $48.96 $117,325 - $176,745
3,610 Added 5.49%
69,390 $2.69 Million
Q1 2021

May 03, 2021
SELL
$41.61 - $54.3 $21,387 - $27,910
-514 Reduced 0.78%
65,780 $3.17 Million
Q4 2020

Feb 12, 2021
BUY
$25.27 - $54.9 $128,093 - $278,288
5,069 Added 8.28%
66,294 $3.45 Million
Q3 2020

Nov 09, 2020
BUY
$18.49 - $27.24 $107,149 - $157,855
5,795 Added 10.45%
61,225 $1.64 Million
Q2 2020

Aug 10, 2020
BUY
$8.9 - $21.84 $22,597 - $55,451
2,539 Added 4.8%
55,430 $1.03 Million
Q1 2020

May 15, 2020
BUY
$7.14 - $15.99 $38,448 - $86,106
5,385 Added 11.34%
52,891 $520,000
Q4 2019

Feb 14, 2020
SELL
$5.1 - $11.2 $6,844 - $15,030
-1,342 Reduced 2.75%
47,506 $527,000
Q3 2019

Nov 12, 2019
BUY
$5.38 - $8.99 $5,874 - $9,817
1,092 Added 2.29%
48,848 $276,000
Q2 2019

Aug 14, 2019
BUY
$6.27 - $8.65 $46,623 - $64,321
7,436 Added 18.44%
47,756 $413,000
Q1 2019

May 13, 2019
SELL
$4.02 - $8.04 $277 - $554
-69 Reduced 0.17%
40,320 $324,000
Q4 2018

Feb 14, 2019
SELL
$3.44 - $5.76 $2,469 - $4,135
-718 Reduced 1.75%
40,389 $165,000
Q3 2018

Nov 14, 2018
SELL
$5.15 - $14.0 $9,558 - $25,984
-1,856 Reduced 4.32%
41,107 $230,000
Q2 2018

Aug 14, 2018
BUY
$12.5 - $15.0 $77,300 - $92,760
6,184 Added 16.81%
42,963 $565,000
Q1 2018

May 15, 2018
SELL
$8.7 - $16.8 $17,199 - $33,213
-1,977 Reduced 5.1%
36,779 $522,000
Q4 2017

Feb 08, 2018
BUY
$7.35 - $12.3 $17,338 - $29,015
2,359 Added 6.48%
38,756 $318,000
Q3 2017

Nov 14, 2017
BUY
$10.0 - $12.7 $363,970 - $462,241
36,397
36,397 $431,000

Others Institutions Holding TGTX

# of Institutions
373
Shares Held
85.6M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.79B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email